Trial Profile
Efficacy of sorafenib in patients with recurrent hepatocellular carcinoma after liver transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Feb 2017
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 10 Feb 2017 New trial record